Andrew H. Karaba

1.2k total citations
44 papers, 567 citations indexed

About

Andrew H. Karaba is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Andrew H. Karaba has authored 44 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 14 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Andrew H. Karaba's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (15 papers) and Cytomegalovirus and herpesvirus research (9 papers). Andrew H. Karaba is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (15 papers) and Cytomegalovirus and herpesvirus research (9 papers). Andrew H. Karaba collaborates with scholars based in United States, Israel and Germany. Andrew H. Karaba's co-authors include Sarah J. Kopp, Richard Longnecker, Andrea L. Cox, Joel N. Blankson, Bezawit A. Woldemeskel, Caroline C. Garliss, Oliver Laeyendecker, Evan J. Beck, William A. Werbel and Dorry L. Segev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Andrew H. Karaba

37 papers receiving 563 citations

Peers

Andrew H. Karaba

EPIDE

IMMUN

Massimiliano Secchi Italy

Guha Asthagiri Arunkumar United States

Lukas Weseslindtner Austria

Maria R. Farcet Austria

Rhys Pryce United Kingdom

Marina Johnson United Kingdom

Carolyn M. Boudreau United States

Jessica Tan United States

Zhong‐Tao Xin China

Teresa Aydillo United States

Massimiliano Secchi Italy

Andrew H. Karaba

367 ×1.2

185 ×1.0

EPIDE

94 ×0.7

IMMUN

116 ×0.9

18 ×0.3

Citations per year, relative to Andrew H. Karaba Andrew H. Karaba (= 1×) peers Massimiliano Secchi

Countries citing papers authored by Andrew H. Karaba

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Karaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Karaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Karaba more than expected).

Fields of papers citing papers by Andrew H. Karaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Karaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Karaba. The network helps show where Andrew H. Karaba may publish in the future.

Co-authorship network of co-authors of Andrew H. Karaba

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew H. Karaba. A scholar is included among the top collaborators of Andrew H. Karaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew H. Karaba. Andrew H. Karaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsieh, Leon L., Elizabeth A. Thompson, Weiqiang Zhou, et al.. (2025). SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19. Science Translational Medicine. 17(799). eadn7527–eadn7527. 1 indexed citations

Sachithanandham, Jaiprasath, John S. Lee, Janna R. Shapiro, et al.. (2025). A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching. Microbiology Spectrum. 13(3). e0219024–e0219024.

Panda, Snigdha, Jennifer L. Alejo, Yolanda Eby, et al.. (2024). Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 79(3). 652–655. 2 indexed citations

Andargie, T., Oren Gordon, Yi Wang, et al.. (2024). Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 2019. The Journal of Infectious Diseases. 230(2). e305–e317.

McAteer, John, Dorry L. Segev, Douglas Mogul, et al.. (2024). COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children. npj Vaccines. 9(1). 73–73. 3 indexed citations

Saharia, Kapil, Andrew H. Karaba, Nancy Law, et al.. (2024). Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey. Transplant Infectious Disease. 26(5). e14342–e14342. 2 indexed citations

Durand, Christine M., Hannah C. Sung, Olivia S. Kates, et al.. (2024). Building a successful transplant research center: Blueprints and barriers. Transplant Infectious Disease. 26(6). e14373–e14373. 1 indexed citations

Andargie, T., Tom Hill, Weiqiang Zhou, et al.. (2023). Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 133(21). 7 indexed citations

Alejo, Jennifer L., Teresa Po‐Yu Chiang, Robin K. Avery, et al.. (2023). Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk. Clinical Transplantation. 37(4). e14913–e14913. 5 indexed citations

10.

Thompson, Elizabeth A., Jennifer L. Alejo, Hady Samaha, et al.. (2023). Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients. JCI Insight. 8(10). 8 indexed citations

11.

Chiang, Teresa Po‐Yu, Jennifer L. Alejo, Jonathan Mitchell, et al.. (2022). Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination. American Journal of Transplantation. 22(9). 2254–2260. 11 indexed citations

12.

Woldemeskel, Bezawit A., Caroline C. Garliss, Evan J. Beck, et al.. (2022). SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge. JCI Insight. 7(10). 12 indexed citations

13.

Woldemeskel, Bezawit A., et al.. (2022). Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients. Clinical Infectious Diseases. 75(9). 1652–1654. 3 indexed citations

14.

Karaba, Andrew H., Weiqiang Zhou, Shuai Li, et al.. (2022). Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 76(3). e495–e498. 3 indexed citations

15.

Karaba, Andrew H., et al.. (2022). Herpesviruses and Inflammasomes: One Sensor Does Not Fit All. mBio. 13(1). e0173721–e0173721. 8 indexed citations

16.

Karaba, Andrew H., Weiqiang Zhou, Leon L. Hsieh, et al.. (2021). Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology. Clinical Infectious Diseases. 74(2). 254–262. 29 indexed citations

17.

Karaba, Andrew H., William A. Werbel, M. Veronica Dioverti, et al.. (2021). Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease. Transplant Infectious Disease. 23(4). e13682–e13682. 4 indexed citations

18.

Queen, Jessica, Sara M. Karaba, John S. Albin, et al.. (2021). The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019. The Journal of Infectious Diseases. 224(9). 1452–1454. 1 indexed citations

19.

Ignatius, Elisa H., Kunbo Wang, Andrew H. Karaba, et al.. (2020). Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis. Open Forum Infectious Diseases. 8(1). ofaa598–ofaa598. 20 indexed citations

20.

Karaba, Andrew H., Paul W. Blair, Kevin Martin, et al.. (2019). The Effects of a Systemwide Diagnostic Stewardship Change on West Nile Virus Disease Ordering Practices. Open Forum Infectious Diseases. 6(12). ofz488–ofz488. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact